Trials / Conditions / Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

6 registered clinical trials studyying Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma.

Status	Trial	Sponsor	Phase
Completed	Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivar NCT02538510	University of Washington	Phase 1 / Phase 2
Terminated	Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer NCT02388932	Case Comprehensive Cancer Center	N/A
Terminated	Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Ne NCT02196168	National Cancer Institute (NCI)	Phase 2
Completed	Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer NCT01254617	National Cancer Institute (NCI)	Phase 1
Completed	Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D NCT01256385	National Cancer Institute (NCI)	Phase 2
Completed	Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer NCT00458978	National Cancer Institute (NCI)	Phase 2